BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 17623039)

  • 1. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
    Uversky VN
    J Neurochem; 2007 Oct; 103(1):17-37. PubMed ID: 17623039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein misfolding and neurodegenerative diseases.
    Uversky VN
    Curr Protein Pept Sci; 2008 Oct; 9(5):507-40. PubMed ID: 18855701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
    Liu IH; Uversky VN; Munishkina LA; Fink AL; Halfter W; Cole GJ
    Glycobiology; 2005 Dec; 15(12):1320-31. PubMed ID: 16037493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
    Popescu A; Lippa CF; Lee VM; Trojanowski JQ
    Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.
    Wakabayashi K; Engelender S; Tanaka Y; Yoshimoto M; Mori F; Tsuji S; Ross CA; Takahashi H
    Acta Neuropathol; 2002 Mar; 103(3):209-14. PubMed ID: 11907799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein: normal function and role in neurodegenerative diseases.
    Norris EH; Giasson BI; Lee VM
    Curr Top Dev Biol; 2004; 60():17-54. PubMed ID: 15094295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Synuclein is phosphorylated in synucleinopathy lesions.
    Fujiwara H; Hasegawa M; Dohmae N; Kawashima A; Masliah E; Goldberg MS; Shen J; Takio K; Iwatsubo T
    Nat Cell Biol; 2002 Feb; 4(2):160-4. PubMed ID: 11813001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge].
    Hauw JJ; Hausser-Hauw C; Duyckaerts C
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S59-70. PubMed ID: 14646802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein dysfunction in Lewy body diseases.
    Tofaris GK; Spillantini MG
    Mov Disord; 2005 Aug; 20 Suppl 12():S37-44. PubMed ID: 16092089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
    Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of alpha-synuclein in neurodegenerative diseases.
    Bennett MC
    Pharmacol Ther; 2005 Mar; 105(3):311-31. PubMed ID: 15737408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
    van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
    J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Synucleinopathy models and human neuropathology: similarities and differences.
    Kahle PJ
    Acta Neuropathol; 2008 Jan; 115(1):87-95. PubMed ID: 17932682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights on physiological functions and pathological effects of alpha-synuclein.
    Bisaglia M; Mammi S; Bubacco L
    FASEB J; 2009 Feb; 23(2):329-40. PubMed ID: 18948383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
    Jiang C; Chang JY
    Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein aggregation mechanisms in synucleinopathies: commonalities and differences.
    Beyer K; Ariza A
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):965-74. PubMed ID: 17984679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology of synuclein aggregates.
    Duda JE; Lee VM; Trojanowski JQ
    J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.